My Market Wizard

GSK plc 6-K Analysis & Summary – 3/14/2025

⚠️This is not investment advice.

⚠️ This is an experimental project and this report is for informational purposes only and should not be considered investment advice. Conduct your own thorough research and consult with a qualified financial advisor before making any investment decisions. ⚠️

GSK plc

Filing date:

03/14/2025

TLDR:

GSK plc announces the purchase of 755,000 ordinary shares as part of its existing buyback program.

ELI5:

GSK, a pharmaceutical company, bought back some of its own stock to hold as treasury shares. This is part of a plan they announced earlier to buy back shares.

Accession #:

0001654954-25-002757

Published on

Analyst Summary

  • GSK plc repurchased 755,000 ordinary shares on March 13, 2025, with prices ranging from 1,488.50p to 1,507.50p per share and a volume-weighted average price of 1,499.80p.
  • The repurchased shares will be held as treasury shares, reducing the number of outstanding shares available to the public.
  • The buyback is part of an existing program announced on February 24, 2025, and was executed through Citigroup Global Markets Limited.
  • Since February 24, 2025, GSK has purchased a total of 9,771,042 ordinary shares.
  • Following the purchase, GSK holds 178,841,345 ordinary shares in treasury and has 4,136,347,996 ordinary shares in issue (excluding treasury shares).
  • The total number of voting rights in the Company is 4,136,347,996.

⚠️ This is an experimental project and this report is for informational purposes only and should not be considered investment advice. Conduct your own thorough research and consult with a qualified financial advisor before making any investment decisions. ⚠️